| Description |
1 online resource |
| Series |
Public health in the 21st century series |
|
Nova biomedical |
|
Pharmacology--research, safety testing and regulation |
|
Public health in the 21st century series.
|
|
Nova biomedical
|
|
Pharmacology-research, safety testing, and regulation series.
|
| Contents |
""ACETAMINOPHEN ""; ""ACETAMINOPHEN ""; ""CONTENTS ""; ""PREFACE ""; ""ACETAMINOPHEN (PARACETAMOL): PROPERTIES, CLINICAL USES, AND ADVERSE EFFECTS""; ""ABSTRACT ""; ""1. INTRODUCTION ""; ""2. PROPERTIES ""; ""2.1. Chemistry ""; ""2.2. Pharmacokinetics ""; ""2.2.1. Absorption ""; ""2.2.1.1. Immediate Release ""; ""2.2.1.2. Extended Release ""; ""2.2.1.3. Intravenous ""; ""2.2.2. Distribution ""; ""2.2.2.1. Spinal Fluid""; ""2.2.2.2. Placental Barrier ""; ""2.2.2.3. Breast Milk ""; ""2.2.3. Metabolism ""; ""2.2.4. Elimination ""; ""2.2.5. Fetus, Neonates, Infants, and Children"" |
|
""2.2.6. Geriatric """"3. CLINICAL USES ""; ""3.1. Antipyresis ""; ""3.2. Analgesia ""; ""4. SPECIAL POPULATIONS ""; ""4.1. Chronic Liver Disease ""; ""4.2. Renal Disease ""; ""4.3. Calorie Restricted Patients ""; ""4.4. HIV ""; ""4.5. Gilbert�s Syndrome ""; ""5. ADVERSE EVENTS ""; ""5.1. Allergy and Hypersensitivity ""; ""5.2. Central Nervous System ""; ""5.3. Gastrointestinal ""; ""5.4. Hemotologic and Hemostatic ""; ""5.5. Hepatic Toxicity ""; ""5.6. Pregnancy and Lactation ""; ""5.7. Renal ""; ""6. DDIS ""; ""6.1. Overdose ""; ""6.1.1. NAC Treatment "" |
|
""7. ACETAMINOPHEN FORMULATIONS """"7.1. Combinations ""; ""7.2. IV Formulation ""; ""CONCLUSION ""; ""REFERENCES ""; ""CLINICAL AND EXPERIMENTAL RELEVANCE OF HYPOTHERMIA IN ACETAMINOPHEN HEPATOTOXICITY ""; ""ABSTRACT ""; ""1. INTRODUCTION ""; ""2. APAP-INDUCED HEPATOTOXICITY IN PATIENTS WITH ALF""; ""3. APAP-INDUCED HEPATOTOXICITY IN EXPERIMENTAL MODELS""; ""3.a. Determinants of APAP-Induced Hepatotoxicity in Experimental Animal Models ""; ""3.b. Histopathology ""; ""4. MECHANISMS OF APAP-INDUCED LIVER INJURY ""; ""5. BODY TEMPERATURE, APAP AND THE LIVER "" |
|
""5.a. Reduction of Body Temperature Due to APAP in Humans """"5.b. Reduction of Body Temperature in Experimental Animal Models of Liver Injury""; ""6. RELEVANCE OF BODY TEMPERATURE FOR APAP-INDUCED ALF ""; ""6.1. Effects of Hypothermia on the Development of Brain Edema and Intracranial Hypertension in ALF""; ""6.2. Effects of Hypothermia on the Progression of Liver Injury""; ""CONCLUSIONS ""; ""REFERENCES ""; ""NOVEL APPLICATIONS OF ACETAMINOPHEN ""; ""ABSTRACT ""; ""1.INTRODUCTION ""; ""2. CHRONIC ACETAMINOPHEN INGESTION CAN IMPROVE BLOOD GLUCOSE CONTROL "" |
|
""3. LONG TERM ACETAMINOPHEN INGESTION CAN IMPROVE SKELETAL MUSCLE STRUCTURE AND FUNCTION""""4. ACETAMINOPHEN POSSESSES CARDIOPROTECTIVE AND NEUROPROTECTIVE PROPERTIES ""; ""5. ACETAMINOPHEN EXHIBITS POTENT ANTIOXIDANT ACTIVITY ""; ""CONCLUSIONS AND PERSPECTIVES ""; ""CONFLICT OF INTEREST STATEMENT ""; ""ACKNOWLEDGMENTS ""; ""REFERENCES ""; ""ADVANCED METHODS FOR THE REMOVAL OF ACETAMINOPHEN FROM WATER ""; ""ABSTRACT ""; ""1. INTRODUCTION ""; ""2. PHARMACEUTICALS AS EMERGENT POLLUTANTS ""; ""3. ACETAMINOPHEN IN WATER RESOURCES ""; ""4. ACETAMINOPHEN REMOVAL AND DEGRADATION "" |
| Bibliography |
Includes bibliographical references and index |
| Notes |
English |
|
Description based on print version record |
| Subject |
Acetaminophen.
|
|
Acetaminophen
|
|
MEDICAL -- Pain Medicine.
|
|
Acetaminophen
|
|
Analgesics
|
| Form |
Electronic book
|
| Author |
Javaherian, Atash, editor of compilation
|
|
Latifpour, Pasha, editor of compilation
|
| LC no. |
2019714237 |
| ISBN |
9781619423756 |
|
1619423758 |
|
